Evidence map›Paper›PMID 33097653›Full record

Observational studyESMO open2020

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy.

Dawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, Kamil Kuć, Anna Walerzak, Michal Wilk, Tomasz Ciszewski, Sylwia Kopeć, Karolina Hryń, Piotr Rutkowski and 3 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in ESMO open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 6 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 6 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Counting the social, psychological, and economic costs of COVID-19 for cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Dawid SigorskiDepartment of Oncology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland. Electronic address: dawidsigorski@wp.pl.
Paweł SobczukDepartment of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Małgorzata OsmolaDepartment of Hematology, Transplantation and Internal Medicine, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.
Kamil KućDepartment of Oncology, St. Pio's Provincial Hospital, Przemyśl, Poland.
Anna WalerzakClinical Department of Oncological Surgery, Warmian-Masurian Cancer Center of The Ministry of The Interior and Administration's Hospital, Olsztyn, Poland.
Michal WilkDepartment of Oncology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.
Tomasz CiszewskiDepartment of Oncology, St. Pio's Provincial Hospital, Przemyśl, Poland.
Sylwia KopećDepartment of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Karolina HryńDepartment of Oncology, St. Pio's Provincial Hospital, Przemyśl, Poland.
Piotr RutkowskiDepartment of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Rafał StecDepartment of Oncology, Medical University of Warsaw, Warsaw, Poland.
Cezary SzczylikDepartment of Oncology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.
Lubomir BodnarClinical Department of Oncology and Immuno-Oncology, Warmian-Masurian Cancer Center of The Ministry of The Interior and Administration's Hospital, Olsztyn, Poland.
The Maria Sklodowska-Curie National Research Institute of Oncology · PLMedical University of Warsaw · PLUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLife-threatening diseases have a negative impact on emotional well-being and psychosocial functioning. This study aimed to assess the relationship between the level of anxiety caused by a neoplasm and the threat of coronavirus infection among patients with cancer actively treated with systemic therapy during the COVID-19 pandemic. Additionally, we searched for clinical factors associated with a higher level of anxiety.

methodsIn this multicentre, prospective, non-interventional study conducted in Poland, we enrolled 306 actively treated patients with cancer and collected their clinical data, including age, gender, cancer type and treatment intention. The fear/anxiety of SARS-CoV-2 were rated in Fear of COVID-19 Scale (SRA-FCV-19S) and Numerical Anxiety Scale (SRA-NAS). The fear and anxiety associated with cancer (CRA) were rated with the NAS (CRA-NAS).

resultsThe mean level of SRA-FCV-19S was 18.5±7.44, which was correlated with the SRA-NAS (r=0.741, p<0.001). SRA-FCV-19S was significantly higher in women versus men (20.18±7.56 vs 16.54±6.83; p<0.001) and was tumour type-dependent (p=0.037), with the highest anxiety observed in patients with breast cancer (17.63±8.75). In the multivariate analysis, only the female gender was significantly associated with higher SRA. CRA-NAS was higher in women versus men (7.07±2.99 vs 5.47±3.01; p<0.001), in patients treated with curative versus palliative intention (7.14±3.06 vs 5.99±3.06; p=0.01) and in individuals aged ≤65 years versus >65 years (6.73±2.96 vs 5.66±3.24; p=0.007).

conclusionsFor an actively treated patient with cancer, cancer remains the main life-threatening disease during the COVID-19 pandemic. The need for more attentive psychological care should be provided especially to female patients, patients with breast cancer, those under 65 years of age and treated with curative intention, as these factors are associated with a higher level of anxiety.

Indexed as

BetacoronavirusAdultAgedAged, 80 and overAnxietyBreast NeoplasmsCoronavirus InfectionsCOVID-19FearFemaleGastrointestinal NeoplasmsHumansMaleMiddle AgedMultivariate AnalysisPandemicsanxietycancerpandemicSARS-CoV-2treatment

Identifiers

PMID33097653
PMCPMC7590347
OpenAlexW3094583861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.